B2.071 Acetaminophen Pharmacokinetics Flashcards
therapeutic dose (1.5 g) distribution through pathways
Glucuronride- 0.85 g Sulfate- 0.45 g NAPQI - 0.08 g GSH - 0.07 g Protein Adducts - 0.01 g
max therapeutic dose (4 g) distribution through pathways
Glucuronride- 3 g Sulfate- 0.5 g NAPQI - 0.4 g GSH - 0.3 g Protein Adducts - 0.04 g
double max therapeutic dose (8 g) distribution through pathways
Glucuronride- 4.5 g Sulfate- 0.5 g NAPQI - 2 g GSH - 1.6 g Protein Adducts - 0.4 g
toxic/lethal dose (8 g) distribution through pathways
Glucuronride- 4.5 g Sulfate- 0.5 g NAPQI - 12 g GSH - 2 g Protein Adducts - 9 g
what is the primary substrate that prevents NAPQI binding to protein?
glutathione
GSH depletion = protein binding
how do APAP protein adducts initiate toxicity?
the change in structure of the proteins (with addition of the NAPQI) alter the function, resulting in hepatotoxicity
in what order do the different APAP metabolic pathways deplete?
sulfation
glucuronidation
GSH scavenging of NAPQI
what cellular component does NAPQI primarily act against?
mitochondria
modifies their proteins, makes them leaky
unleashes mediators of toxicity and initiated oncotic necrosis
what is one reason for unintentional overdoses?
polypharmacy
taking multiple meds for symptoms that contain APAP and then taking APAP itself
how is APAP overdose related to opioids?
many opioids have been compounded with APAP for synergistic effects
individuals who are opioid tolerant or engage in excessive use can suffer from APAP overdose
what is the APAP dose limit set by the FDA?
325 mg per pill
what are 3 primary reasons for pharmacokinetic variability?
genetics
expression
inhibition
genetics
genetic variation in genes coding for drug metabolizing enzymes often decrease activity
expression
drugs or chemical exposures from diet, social habits, or the environment can upregulate the expression of drug metabolizing enzymes
inhibition
drugs or chemical exposures from diet, social habits, or the environment can inhibit drug metabolizing enzymes